awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48316015-68BC252A-0755-4059-8B49-A40E0CFEAC59
Q48316015-68BC252A-0755-4059-8B49-A40E0CFEAC59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48316015-68BC252A-0755-4059-8B49-A40E0CFEAC59
BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints.
P2860
Q48316015-68BC252A-0755-4059-8B49-A40E0CFEAC59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48316015-68BC252A-0755-4059-8B49-A40E0CFEAC59
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e9b552291bd227b841dcdbd3106e02101d78872
P2860
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi.